Multiple Myeloma Market

1
Multiple Myeloma Market 
sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
2
Multiple Myeloma Market Global Scenario, Market
Size, Outlook, Trend, and Forecast, 2019 2028

• The Multiple Myeloma Market would experience the
  CAGR of 4.5 from 2021 to 2028. The major
  countries contributing to the growth of the
  market are the United States, Eu5 (the UK,
  Germany, France, Italy, Spain), China and Japan.
  Multiple myeloma (MM), is a rare type of cancer
  formed in the white blood cell also called as
  plasma cell. Normal plasma cells are an important
  part of immune system which are found in the bone
  marrow (soft tissue bones). The immune system is
  made of several types of cells which work
  together to fight infections and other diseases.
  Lymph cells are the main types of white blood
  cells in immune system and also includes T and B
  cells. These cells can be in any areas of the
  body like nymph nodes, bone marrow, intestines,
  and bloodstream. When B cells counter to an
  infection, they mature and changes to plasma
  cells. Plame cells produces antibodies, which can
  help the body attack and then kill germs.
• When plasma cells become uncontrollable and grow
  out of control then it becomes cancerous, this is
  termed as multiple myeloma. These plasma cells
  make an abnormal protein or antibody which is
  known by several names like monoclonal
  immunoglobulin, monoclonal protein, M-spike.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
3
Market Dynamics

• Increased prevalence of multiple myeloma market
  augments the growth of the market as numerous
  forms of blood cancer is increasing including the
  multiple myeloma which is considered as rare type
  which needs efficient and advanced therapeutics
  resulting in positive clinical outcomes for
  patients. There is increase in RD activity which
  is efficient in boosting the multiple myeloma
  market. Despite the increase of these cases
  higher costs of treatment leads to limited market
  growth also lack of awareness and appropriate
  payment plans in the emerging countries hinders
  the growth.
• North America hold the substantial market share
  at present. This is characterized by increased
  prevalence and demand for the treatment coupled
  with increase in the diagnosis of disease by
  adopting advanced therapeutics. All these factors
  along with high healthcare expenditure, patient
  population for new treatments and presence of
  upcoming launches are responsible for substantial
  market share of the region. The total cases
  reported in the year 2020 was 91,693 in the 8 MM
  of which US accounted 32,270. In the case of EU-5
  countries, Germany reported maximum cases of
  Multiple Myeloma of 21,116 in 2020. The cases in
  males are more likely to develop Multiple Myeloma
  than females (about 55 percent of cases).

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
4
Multiple Myeloma Diagnosis requires

• Plasma cell tumor.
•  Any one of the below.
• High blood calcium cells
• Poor kidney function
• Low RBC
• Holes in bones from tumor
• Above 60 plasma cells in bone marrow
• Multiple Myeloma Market is segmented based on
  therapy and by drug type, distribution channel,
  and region. Based on therapy, it categorized as
  targeted therapy, biologic therapy, and
  chemotherapy. On the basis of drug type, it is
  categorized as Immunomodulatory Drugs, Proteasome
  Inhibitors, Histone Deacetylase Inhibitors,
  Monoclonal Antibody Drugs, and Steroids.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
5

• Furthermore, based on distribution it is
  categorized as Hospital Pharmacies, Retail
  Pharmacies Drug Stores and Online Pharmacies.
  Moreover, on the basis of geography it is
  categorized as North America (US, Canada, Rest of
  North America), Europe (UK, Germany, France,
  Italy, Spain, Scandinavia, Rest of Europe), Asia
  Pacific (India, China, Japan, Australia, Rest of
  Asia Pacific), Rest of the World (Latin America
  (Brazil, Mexico, Rest of Latin America), Middle
  East Africa (South Africa, GCC, Rest of Middle
  East Africa)).
• Global market reflects an increasingly intense
  competition scene with the presence of many
  market leaders of oncology with them enlarge
  portfolio of cancer treatment. Key major players
  in the multiple myeloma market are Takeda
  Pharmaceutical Company Limited, Celegene
  Corporation, Kyprolis, Bristol Myers Squibb
  Company, AbbVie Inc., Sanofi and others.

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
6
Global Multiple Myeloma Market Segmentation and
Scope

• By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies Drug Stores
• Online Pharmacies
• By Region
• North America
• US
• Canada
• Rest of North America
• Europe
• UK
• Germany
• France

• By Therapy
• Targeted Therapy
• Biologic Therapy
• Chemotherapy
• Others
• By Drug Type
• Immunomodulatory Drugs
• Proteasome Inhibitors
• Histone Deacetylase Inhibitors
• Monoclonal Antibody Drugs
• Steroids
• Others

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
7

• Italy
• Spain
• Scandinavia
• Rest of Europe
• Asia Pacific
• India
• China
• Japan

• Australia
• Rest of Asia Pacific
• Rest of World (ROW)
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• South Africa
• GCC

• The prominent players involved in the global
  multiple myeloma market includes
• Takeda Pharmaceutical Company Limited
• Celegene Corporation
• Kyprolis
• Bristol Myers Squibb Company
• AbbVie Inc.
• Sanofi

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research
8
Contact us

• Accurize Market Research Pvt. Ltd.
• PATNA OFFICE K-129,
• PC COLONY,
• HANUMAN NAGAR,
• KANKARBAGH, PATNA, PIN-800020
• CONTACT NO1-339-368-6383
• Emailhelp_at_accurizemarketresearch.com

sales_at_accurizemarketresearch.com Copyright 2021
Accurize Market Research